October 2019
Feeding the Grant Pipeline through Philanthropy

When the Texas Biomedical Forum presents scientists with money for pilot research projects, they are planting the seeds of success for later, larger grant applications. For example, Professor Jordi Torrelles, Ph.D., was the recipient of a $60,000  2018 Forum Grant funding his research on a new inexpensive, easy-to-use test for drug resistant tuberculosis. That project has now been funded by a two-year NIH exploratory grant for $403,496. A $40,000 2017 Forum grant to Professor Larry Schlesinger, M.D., Assistant Professor Smita Kulkarni, Ph.D., and Staff Scientist Eusondia Arnett, Ph.D., yielded a $536,250 two-year NIH grant to study how HIV alters the formation of lesions in the lungs that make patients more susceptible to TB infection. A 2016 Forum grant of $50,000 to Dr. Kulkarni funded research that justified a two-year $526,625 NIH grant to further her studies into the roles of long non-coding RNAs interacting with HIV protein.. Investment by our generous donors is growing the future of biomedical research!
Novel TB Research Could Lead to New Host Drug Targets

Mycobacterium tuberculosis (Mtb)
Researchers at Texas Biomed are zeroing in on a new way to target tuberculosis (TB) infection. The National Institutes of Health (NIH) has awarded a four-year, $2.8 million grant for scientists to study the role of lung macrophages (immune cells) in metabolic and inflammation responses to TB. Findings could open the door to a new set of biological pathways critical to the body's response to TB infection in the lungs.

"This newest research has the most clear-cut translation potential in terms of leading to a new strategy for host-directed therapy for TB," said Texas Biomed Professor and President/CEO Larry Schlesinger, M.D., who is Principal Investigator of the study. Learn more about this exciting new project by clicking here.
Partnering for Precision Therapeutics

Texas Biomed is partnering with three other local research institutions to form the San Antonio Partnership for Precision Therapeutics. The process of precision therapeutics ultimately leads to breakthrough treatments that can be individualized to specific patient populations.UT Health San Antonio, Texas Biomed, UTSA, UT Health San Antonio and Southwest Research Institute are providing $800,000 collectively to address the specific and diverse medical needs of the city's population while serving as a model for the development of therapies to improve medical treatment around the world. To learn more, click here.
Family Night 2019
More than 500 Texas Biomed staffers and their families flooded the campus in mid-October for our 2nd Annual Family Night! This is a fun and educational a way for us to teach our parents, spouses and children about the ways Texas Biomed is protecting the world against the deadliest diseases impacting our global family. The event featured tables where visitors could make their own microbes our of Play-Doh, learn about what our scientists, veterinarians and pathologists do every day, and even try on the personal protective equipment researchers wear in laboratories. We love sharing our science! 
New Podcasts
TXBioBytes from Texas Biomed

                        Vet Tech podcast

Wendy Rigby
Media and Communications Specialist
8715 W. Military Dr., San Antonio, TX 78227